Literature DB >> 9226688

Host-protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen.

M W Lightowlers1, J G Waterkeyn, J S Rothel, C G Gauci, G B Harrison.   

Abstract

The protective efficacy of a recombinant Taenia ovis vaccine antigen, 45W, was compared in sheep vaccine trials with antigen expressed by the full length 45W cDNA and by incomplete copies of the cDNA. Vaccine, trials were also carried out using antigen expressed by a cDNA (45S) having a sequence similar, but not identical, to 45W. Stability of the 45W antigen expressed in Escherichia coli was found to be increased after deletion of cDNA sequence encoding 19 COOH-terminal amino acids. This truncated form of the antigen was designated 45WB/X. Vaccination of sheep with antigen expressed by 45W, 45WB/X, as well as full length 45W and 45S cDNAs, induced high levels of protection. Vaccination with antigen expressed by an incomplete copy of the 45S cDNA clone did not induce protection. Comparison of deduced amino acid sequences for these clones suggests that the host-protective epitope(s) of the 45W antigen occur on either or both of the 23 and 9 amino acid peptides at the amino and carboxyl termini of 45W, respectively. Antibody binding epitopes of 45W were investigated in ELISA using overlapping 9 amino acid peptides. Protection was found to correlate with the induction of antibody to two 9 amino acid peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9226688     DOI: 10.1046/j.1365-3024.1996.d01-20.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

1.  Strategies for optimal expression of vaccine antigens from Taeniid cestode parasites in Escherichia coli.

Authors:  Charles Gauci; David Jenkins; Marshall W Lightowlers
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

2.  Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.

Authors:  Ana Flisser; Charles G Gauci; André Zoli; Joel Martinez-Ocaña; Adriana Garza-Rodriguez; Jose Luis Dominguez-Alpizar; Pablo Maravilla; Rossana Rodriguez-Canul; Guillermina Avila; Laura Aguilar-Vega; Craig Kyngdon; Stanny Geerts; Marshall W Lightowlers
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

3.  Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine.

Authors:  Dunia Rassy; Raúl J Bobes; Gabriela Rosas; Victor H Anaya; Klaus Brehm; Beatriz Hernández; Jacquelynne Cervantes; Saúl Pedraza; Julio Morales; Nelly Villalobos; Aline S de Aluja; Juan P Laclette; Caris M Nunes; Germano F Biondi; Gladis Fragoso; Marisela Hernández; Edda Sciutto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

4.  Antibody responses to the host-protective Taenia solium oncosphere protein TSOL18 in pigs are directed against conformational epitopes.

Authors:  E Assana; C G Gauci; C T Kyngdon; A P Zoli; P Dorny; S Geerts; M W Lightowlers
Journal:  Parasite Immunol       Date:  2010-06       Impact factor: 2.280

5.  Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli.

Authors:  Charles Gauci; César Jayashi; Marshall W Lightowlers
Journal:  Bioengineered       Date:  2012-11-29       Impact factor: 3.269

6.  Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens.

Authors:  Charles G Gauci; César M Jayashi; Armando E Gonzalez; Julia Lackenby; Marshall W Lightowlers
Journal:  Vaccine       Date:  2012-04-19       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.